The News Of Tomorrow, Today
The News Of Tomorrow, Today
Pharmaceuticals
Matt Novak
Ever since the covid-19 pandemic made its way around the world, the question of whether people would accept a potential vaccine has lingered over everything. First, there was the concern that the antivaxxer movement might dissuade people from taking a legitimate vaccine. More recently, the worry has been that U.S….
U.S. Pharmaceutical giant Gilead Sciences on Wednesday retracted its effort to score extended monopoly rights and tax breaks on its antiviral drug remdesivir, which scientists are evaluating as a possible treatment in the novel coronavirus pandemic.
Pharmaceutical giants celebrated the dawn of 2020 in the best way they know how: jacking up the prices of drugs for people in the U.S. that need them.
There are no more articles to be viewed
Haven't registered?
Sign up here
Lost your password?
Click here to reset
Back to Login?
Click here
Subscribe to our newsletter!
Now you can get the top stories from Gizmodo delivered to your inbox. Enter your email below.
By subscribing you agree to our Terms of Use and Privacy Policy.